Plunkett Matthew

CIK 00015575513 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001557551

Recent Transactions

50 trades

Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2020-07-09+77,800→ 77,800 total
Award
CTI BIOPHARMA CORP
Employee Stock Option (Right to Buy)
2017-03-01+60,000→ 60,000 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2016-03-21$0.55/sh−63,874→ 526,210 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.58/sh−1,300→ 598,784 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−200→ 593,804 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.60/sh−900→ 590,084 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−1,500→ 596,248 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−700→ 594,704 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−1,220→ 590,984 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−400→ 598,384 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−700→ 594,004 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−844→ 595,404 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−636→ 597,748 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−500→ 592,204 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-03-04$0.59/sh−1,100→ 592,704 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-02-04$1.16/sh−600→ 601,084 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-02-04$1.17/sh−700→ 600,384 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-02-04$1.15/sh−5,000→ 604,684 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-02-04$1.16/sh−3,000→ 601,684 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-02-04$1.18/sh−300→ 600,084 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-02-04$1.14/sh−400→ 609,684 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-01-04$1.22/sh−1,700→ 612,186 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-01-04$1.20/sh−1,600→ 618,484 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-01-04$1.21/sh−800→ 615,786 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-01-04$1.26/sh−200→ 610,084 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-01-04$1.24/sh−300→ 611,086 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-01-04$1.21/sh−1,900→ 613,886 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-01-04$1.24/sh−202→ 610,884 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-01-04$1.25/sh−600→ 610,284 total
Sale
CTI BIOPHARMA CORP
Common Stock
2016-01-04$1.20/sh−1,898→ 616,586 total
Disposition to Issuer
CTI BIOPHARMA CORP
Performance Rights
2015-12-23−253,438→ 0 total
Award
CTI BIOPHARMA CORP
Employee Stock Option (Right to Buy)
2015-12-23+1,400,000→ 1,400,000 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$1.00/sh−200→ 624,984 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$0.99/sh−200→ 626,284 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$1.00/sh−4,500→ 620,384 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$1.00/sh−100→ 620,284 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$0.99/sh−1,100→ 626,484 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$0.99/sh−600→ 625,684 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$1.01/sh−200→ 620,084 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$1.00/sh−300→ 625,184 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$1.00/sh−100→ 624,884 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$1.00/sh−100→ 625,584 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$0.99/sh−600→ 627,984 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$0.99/sh−200→ 627,784 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$0.99/sh−200→ 627,584 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$1.00/sh−100→ 625,484 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-04$0.99/sh−1,500→ 628,584 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-04$1.39/sh−200→ 632,684 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-04$1.38/sh−3,500→ 632,884 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-04$1.37/sh−1,900→ 638,184 total

Companies

Recent Filings

Address

3101 WESTERN AVENUE, SUITE 600

SEATTLE, WA, 98121

View on SEC.gov